+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Neuregulin Market - Global Forecast 2025-2030- Product Image
Human Neuregulin Market - Global Forecast 2025-2030- Product Image
Sale

Human Neuregulin Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130458
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Advances in human neuregulin science are transforming both life sciences research and therapeutic development, redefining strategies and priorities for biopharma and research leaders navigating a highly segmented and rapidly evolving market.

Market Snapshot of the Human Neuregulin Market

The human neuregulin market is characterized by rising investment in advanced biological research, with strong momentum in cell-to-cell communication and related therapeutic applications. Technology breakthroughs, such as high-throughput screening and artificial intelligence-powered data analytics, are fueling innovation, especially in cardiology and neurodegenerative disease research. Growing global demand, coupled with shifting regulatory and supply chain dynamics, is intensifying competition across the Americas, EMEA, and Asia-Pacific regions.

Scope & Segmentation of the Human Neuregulin Market

This report offers a comprehensive segmentation and analysis of the human neuregulin landscape, covering the following key areas:

  • Application: Research (including in vitro biomarker studies and cell signaling; in vivo physiological models across multiple therapeutic areas), and Therapeutic (notably in cardiology, neurology, and oncology, with specific attention to breast and lung cancer).
  • Type: Peptide (purified natural sequences and synthetic analogs for improved stability and selectivity); Recombinant Protein (produced through microbial or mammalian cell expression systems).
  • End User: Academic research institutes (including hospitals and universities); Contract research organizations (clinical and preclinical focus); Pharmaceutical and biotech companies (large pharma, mid-sized biotech firms, and start-ups).
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina, with emphasis on states like California, Texas, and New York); EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Major Players and Technologies: Key companies including Thermo Fisher Scientific Inc., Merck KGaA, Bio-Techne Corporation, Lonza Group AG, Abcam plc, GenScript Biotech Corporation, Sino Biological Inc., RayBiotech Inc., Creative Biolabs Inc., and BioVision, Inc., deploying high-throughput platforms, single-cell sequencing, and modular manufacturing technologies.

Key Takeaways for Human Neuregulin

  • Human neuregulin’s multi-functionality underpins research advances in cardiac, neurological, and oncological pathways, elevating its status as a sought-after therapeutic candidate.
  • Emerging technologies, particularly AI and machine learning, are catalyzing breakthroughs in biomarker discovery, enabling deeper insights into receptor-ligand interactions and isoform functionality.
  • Supply chain and manufacturing strategies are adapting in response to increased regional tariffs and shifting procurement practices, prompting market participants to diversify sourcing and boost local production.
  • Collaborative consortia are fostering greater assay standardization, transparency, and reproducibility, improving both development timelines and regulatory alignment.
  • Key market leaders are leveraging proprietary technologies and acquisition strategies to expand innovation pipelines and differentiate therapeutic solutions.

Tariff Impact: Navigating Supply Chain and Regulatory Complexity

Recent United States tariff policies have notably increased operational complexity within the human neuregulin supply chain. Procurement teams are shifting sourcing strategies and seeking regional suppliers to manage cost pressures and reduce exposure to global logistics risks. The market is witnessing a rise in domestic manufacturing capacity, with contract development and manufacturing organizations scaling up peptide synthesis and recombinant protein production. Budgeting and project planning now factor in tariff-related contingencies, which has strengthened the focus on supply chain resilience and accelerated development timelines for preclinical studies.

Methodology & Data Sources

Analysis draws on structured interviews with senior R&D leaders, site visits to academic and manufacturing facilities, and review of primary and secondary sources, including journals, patent databases, regulatory documents, and proprietary valuation models. An expert advisory panel validated key findings, and quantitative insights were triangulated with public data and cohort studies for rigor and reliability.

Why This Report Matters

  • Enables senior decision-makers to identify actionable strategies for portfolio diversification and market entry amid region-specific dynamics and evolving regulatory criteria.
  • Offers granular segmentation and in-depth analysis across applications, molecular types, and end user profiles, supporting data-driven investment and partnership decisions.
  • Equips industry leaders to anticipate supply chain shifts, mitigate risks from tariff impacts, and seize emerging growth opportunities.

Conclusion

The human neuregulin market presents compelling innovation and investment prospects, shaped by diverse research domains, regional developments, and an evolving regulatory environment. Strategic alignment around advanced technologies and collaborative models is essential for sustained success.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in recombinant human neuregulin manufacturing platforms for scalable therapeutic production
5.2. Expansion of clinical trial pipelines evaluating human neuregulin for cardiac regeneration therapies
5.3. Strategic partnerships between biotechnology firms and academic institutions to accelerate neuregulin research initiatives
5.4. Emergence of personalized medicine approaches leveraging human neuregulin biomarkers for oncology patient stratification
5.5. Regulatory pathway optimization for human neuregulin based biologics across major pharmaceutical markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Neuregulin Market, by Application
8.1. Introduction
8.2. Research
8.2.1. In Vitro
8.2.1.1. Biomarker Studies
8.2.1.2. Cell Signaling
8.2.2. In Vivo
8.3. Therapeutic
8.3.1. Cardiology
8.3.2. Neurology
8.3.3. Oncology
8.3.3.1. Breast Cancer
8.3.3.2. Lung Cancer
9. Human Neuregulin Market, by Type
9.1. Introduction
9.2. Peptide
9.2.1. Purified
9.2.2. Synthetic
9.3. Recombinant Protein
9.3.1. E Coli Expressed
9.3.2. Mammalian Expressed
10. Human Neuregulin Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.2.1. Hospitals
10.2.2. Universities
10.3. Contract Research Organizations
10.3.1. Clinical
10.3.2. Preclinical
10.4. Pharmaceutical Biotech Companies
10.4.1. Big Pharma
10.4.2. Mid-Size Biotech
10.4.3. Small Biotech
11. Americas Human Neuregulin Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Human Neuregulin Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Human Neuregulin Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Thermo Fisher Scientific Inc.
14.3.2. Merck KGaA
14.3.3. Bio-Techne Corporation
14.3.4. Lonza Group AG
14.3.5. Abcam plc
14.3.6. GenScript Biotech Corporation
14.3.7. Sino Biological Inc.
14.3.8. RayBiotech Inc.
14.3.9. Creative Biolabs Inc.
14.3.10. BioVision, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. HUMAN NEUREGULIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN NEUREGULIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. HUMAN NEUREGULIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. HUMAN NEUREGULIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. HUMAN NEUREGULIN MARKET: RESEARCHAI
FIGURE 22. HUMAN NEUREGULIN MARKET: RESEARCHSTATISTICS
FIGURE 23. HUMAN NEUREGULIN MARKET: RESEARCHCONTACTS
FIGURE 24. HUMAN NEUREGULIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN NEUREGULIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN NEUREGULIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN NEUREGULIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY BIOMARKER STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY BIOMARKER STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CELL SIGNALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CELL SIGNALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY IN VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY IN VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PURIFIED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PURIFIED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY E COLI EXPRESSED, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY E COLI EXPRESSED, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY MAMMALIAN EXPRESSED, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY MAMMALIAN EXPRESSED, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY MID-SIZE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY MID-SIZE BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HUMAN NEUREGULIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 142. CANADA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 143. CANADA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 144. CANADA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 145. CANADA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 146. CANADA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 147. CANADA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 148. CANADA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 149. CANADA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 152. CANADA HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 153. CANADA HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 154. CANADA HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 155. CANADA HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 158. CANADA HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 159. CANADA HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 160. CANADA HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 161. CANADA HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 162. CANADA HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 166. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 167. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 168. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 169. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 170. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 171. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 178. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 179. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 186. MEXICO HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA HUMAN NEUREGULIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 288. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 289. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 290. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 291. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 292. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 293. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 294. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 295. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 300. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 301. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 306. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 307. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 308. GERMANY HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 309. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 312. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 313. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 314. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 315. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 316. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 317. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 318. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 319. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 320. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2018-2024 (USD MILLION)
TABLE 322. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY PEPTIDE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2018-2024 (USD MILLION)
TABLE 324. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY RECOMBINANT PROTEIN, 2025-2030 (USD MILLION)
TABLE 325. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 328. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 329. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 330. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 331. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 332. FRANCE HUMAN NEUREGULIN MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY IN VITRO, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA HUMAN NEUREGULIN MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Neuregulin market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • Lonza Group AG
  • Abcam plc
  • GenScript Biotech Corporation
  • Sino Biological Inc.
  • RayBiotech Inc.
  • Creative Biolabs Inc.
  • BioVision, Inc.

Related Reports

Recombinant Human Neuregulin Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Neuregulin Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Recombinant Human Neuregulin Kit Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Neuregulin Kit Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Human Neuregulin Molecular Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Human Neuregulin Molecular Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Neuregulin Gene Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Neuregulin Gene Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Chronic Heart Failure- Pipeline Insight, 2025 - Product Image

Chronic Heart Failure- Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.